← Back to Clinical Trials
Recruiting NCT03903510

NCT03903510 Virtual Reality During Pediatric Cast Removal

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03903510
Status Recruiting
Phase —
Sponsor Gillette Children's Specialty Healthcare
Condition Fractures, Bone
Study Type INTERVENTIONAL
Enrollment 184 participants
Start Date 2019-05-21
Primary Completion 2021-09

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Virtual Reality (VR)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 184 participants in total. It began in 2019-05-21 with a primary completion date of 2021-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a randomized control trial of Virtual Reality during cast removal procedures at a pediatric tertiary care center.

Eligibility Criteria

Inclusion Criteria: * Sustained a fracture in their arm/leg * No previous experience with a cast removal * Must have at least one wrist free of immobilization (for heart rate monitor) * Parents and patient are English speaking Exclusion Criteria: * Patients with a history of epilepsy, ventricular shunt, motion sickness * Patients with any history of cognitive, visual or hearing impairment

Contact & Investigator

Central Contact

Andrew G Georgiadis, MD

✉ andrewgeorgiadis@gillettechildrens.com

📞 651-602-3262

Principal Investigator

Andrew G Georgiadis, MD

PRINCIPAL INVESTIGATOR

Pediatric Orthopedic Surgeon

Frequently Asked Questions

Who can join the NCT03903510 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 12 Years, studying Fractures, Bone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03903510 currently recruiting?

Yes, NCT03903510 is actively recruiting participants. Contact the research team at andrewgeorgiadis@gillettechildrens.com for enrollment information.

Where is the NCT03903510 trial being conducted?

This trial is being conducted at Saint Paul, United States.

Who is sponsoring the NCT03903510 clinical trial?

NCT03903510 is sponsored by Gillette Children's Specialty Healthcare. The principal investigator is Andrew G Georgiadis, MD at Pediatric Orthopedic Surgeon. The trial plans to enroll 184 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology